期刊文献+

间皮素与肿瘤诊治的相关研究进展 被引量:2

Research Progress of Mesothelin in Tumor Diagnosis and Treatment
下载PDF
导出
摘要 间皮素是一种细胞表面糖蛋白,正常组织中很少表达,但卵巢癌、胰腺癌和恶性间皮瘤等肿瘤组织及血液中高表达.因此,间皮素有助于间皮瘤、卵巢癌、胰腺癌等肿瘤的早期诊断,与肿瘤的分期和预后有关.使用抗毒素、抗间皮素嵌合抗体、抗体-药物结合物、嵌合抗原受体T细胞、间皮素肿瘤疫苗等治疗高表达间皮素的肿瘤的方法正在逐步走向成熟.旨在对间皮素在卵巢癌、胰腺癌、恶性间皮瘤诊断与治疗中的作用作一综述. Mesothelin is a cell surface glycoprotein,with little expression in normal tissues, but highlyexpressed in tumors such as ovarian cancer,pancreatic cancer and malignant mesothelioma. Therefore, mesothelinhelps those tumors' early diagnosis, and is related to tumor staging and prognosis. The use of immunotoxin,anti-mesothelin chimeric antibodies, antibody-drug conjugates, chimeric antigen receptor T cells, mesothelintumor vaccines is progressing towards maturation in the treatment of mesothelin-rich tumors. This article aims toreview the research progress of mesothelin in ovarian cancer,pancreatic cancer, malignant mesothelioma diagnosisand treatment.
出处 《昆明医科大学学报》 CAS 2017年第9期134-139,共6页 Journal of Kunming Medical University
基金 国家自然科学基金资助项目(81160179 81160179) 云南省科技厅-昆明医科大学应用基础研究联合专项基金资助助目(2014FA013 2009ZC100M)
关键词 间皮素 可溶性间皮素相关蛋白或多肽 卵巢癌 恶性间皮瘤 胰腺癌 Mesothelin Soluble mesothelin-related protein or peptide Ovarian cancer Malignantmesothelioma Pancreatic cancer
  • 相关文献

参考文献5

二级参考文献24

  • 1花纯宏,宋林立,王霞灵,吕赛平,罗昔波,伍志杰,冷婵.CA125检测在评价卵巢癌预后中的作用[J].实用医技杂志,2005,12(05B):1236-1239. 被引量:3
  • 2Broos PL,Rommens PM,Geens VR,et al.Pertrochanteric fractures in the elderly.Is the belgian VDP prosthesis the best treatment for unstable fractures with severe comminution[J].Acta Chir Belg,1991,91(5):242. 被引量:1
  • 3Berrino F,De Angelis R,Sant M,et al.Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99:results of the EUROCARE-4 study[J].Lancet Oncol,2007,8(9):773. 被引量:1
  • 4Evans J,Ziebland S,McPherson A.Minimizing delays in ovarian cancer diagnosis:an expansion of Andersen's model of 'total patient delay'[J].Fam Pract,2007,24(1):48. 被引量:1
  • 5Hellstrom I,Hellstrom KE.SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and/or each other[J].Adv Exp Med Biol,2008,622:15. 被引量:1
  • 6McIntosh MW,Drescher C,Karlan B,et al.Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma[J].Gynecol Oncol,2004,95(1):9. 被引量:1
  • 7Obuchowski NA,Lieber ML,Wians FH,Jr.ROC curves in clinical chemistry:uses,misuses,and possible solutions[J].Clin Chem,2004,50(7):1118. 被引量:1
  • 8Cook NR.Statistical evaluation of prognostic versus diagnostic models:beyond the ROC curve[J].Clin Chem,2008,54(1):17. 被引量:1
  • 9Moore RG, MacLaughlan S, Bast RC Jr. Current state of biomarker development for clinical application in epithelial ovarian cancer[J]. Gynecol Oncol, 2010,116 (2) : 240-245. 被引量:1
  • 10Riedinger JM, Eche N, Basuyau JP, et al. Prognostic value of serum CA125 hi-exponential decrease during first line paclitaxel/ platinum chemotherapy: a French muhicentric study [J ]. Gynecol Oneol, 2008,109 (2) : 194-198. 被引量:1

共引文献41

同被引文献23

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部